BioNTech (ADR) (BNTX)
Develops oncology medicines while commercializing the Pfizer-partnered Comirnaty vaccine.
$100.85
vs last close+2.85 (+2.91%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 18.60% | 46.73M ADS | |
|---|---|---|---|
| 318 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 56.90% | 142.95M ADS | |
| 8 holders · as of Sep 18, 2026 | |||
| Other | ≈ 24.50% | 61.53M ADS | |
| remainder | |||
251.20M ADS as of Aug 25, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
The share count is from the company's Mar 2025 annual report; nothing newer is on file here.
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
13F, as of Jun 30, 2026
318 holders · 46.73M shares · 46 new positions · 139 increased · 73 reduced · 31 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| FMR LLC | 7.57M | 3.01% | +1.86M | Aug 13, 2026 |
| Primecap Management Co/CA/ | 3.77M | 1.50% | −21.7K | Aug 14, 2026 |
| Dodge & Cox | 3.68M | 1.46% | +800 | Aug 13, 2026 |
| Flossbach von Storch AG | 2.23M | 0.89% | −1.45M | Aug 10, 2026 |
| T. Rowe Price Investment Management, Inc. | 2.07M | 0.82% | −3.79M | Aug 14, 2026 |
| BlackRock, Inc. | 1.85M | 0.74% | +196.8K | Aug 7, 2026 |
| Temasek Holdings (Private) Ltd | 1.51M | 0.60% | 0 | Aug 7, 2026 |
| BNP Paribas Arbitrage, SNC | 1.32M | 0.53% | −332.3K | Aug 13, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Athos KG | 40.20% | 101.70M | 13G | May 14, 2026 |
| Ugur Sahinincl. Medine GmbH | 15.80% | 40.08M | 13G | May 15, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 18, 2026 | Ugur Sahin10 percent owner, officer: Chief Executive Officer | Sale | 30,000 | $96.22 | 489,209 |
| Sep 17, 2026 | Ugur Sahin10 percent owner, officer: Chief Executive Officer | Sale | 34,000 | $98.60 | 519,209 |
| Sep 16, 2026 | Ugur Sahin10 percent owner, officer: Chief Executive Officer | Sale | 15,000 | $96.09 | 553,209 |
| Sep 15, 2026 | Ugur Sahin10 percent owner, officer: Chief Executive Officer | Sale | 34,000 | $96.49 | 568,209 |
| Sep 14, 2026 | Ugur Sahin10 percent owner, officer: Chief Executive Officer | Sale | 41,000 | $99.45 | 602,209 |
| Sep 11, 2026 | Ugur Sahin10 percent owner, officer: Chief Executive Officer | Sale | 45,000 | $96.93 | 643,209 |
| Sep 10, 2026 | Ugur Sahin10 percent owner, officer: Chief Executive Officer | Sale | 20,500 | $96.31 | 688,209 |
| Sep 9, 2026 | Ugur Sahin10 percent owner, officer: Chief Executive Officer | Sale | 36,000 | $97.78 | 708,709 |
| Sep 8, 2026 | Ugur Sahin10 percent owner, officer: Chief Executive Officer | Sale | 37,000 | $99.20 | 744,709 |
| Sep 4, 2026 | Ugur Sahin10 percent owner, officer: Chief Executive Officer | Sale | 31,500 | $103.52 | 781,709 |
House and Senate disclosures
Not reported.